NovaBridge Biosciences (NBP) Retained Earnings (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Retained Earnings data on file, last reported at -$1.3 billion in Q4 2025.

• Retained Earnings for Q4 2025 came in at -$1.3 billion, down 3.6% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.3 billion (down 3.6% YoY), and the FY2025 annual result was -$1.3 billion, down 3.6% from the prior year.
• Retained Earnings slipped to -$1.3 billion in Q4 2025 per NBP's latest filing, from -$1.3 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $41.4 million in Q4 2023 and troughed at -$681.1 billion in Q4 2021.
• A 5-year average of -$53.3 billion and a median of -$1.3 billion in 2024 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2021 and 2022: Retained Earnings slumped 8887020.65% in 2021, then surged 100.0% in 2022.
• A 5-year view of Retained Earnings shows it stood at -$681.1 billion in 2021, then surged by 100.0% to $30.1 million in 2022, then jumped by 37.82% to $41.4 million in 2023, then slumped by 3204.21% to -$1.3 billion in 2024, then decreased by 3.6% to -$1.3 billion in 2025.
• Business Quant data shows NBP's Retained Earnings at -$1.3 billion in Q4 2025, -$1.3 billion in Q3 2025, and -$1.3 billion in Q2 2025.